IL-11 Inhibition Extends Healthspan and Lifespan in Mammals
Recent research reveals that blocking IL-11 signaling slows aging and extends healthspan in mammals. This discovery opens new pathways for developing longevity therapies targeting age-related decline.
Interleukin-11 (IL-11) is a signaling molecule that regulates inflammatory processes in the body. As we age, its activity increases, driving chronic inflammation and age-related diseases. Researchers found that inhibiting this pathway slows tissue damage accumulation and extends both lifespan and healthspan.
How the Mechanism Works
IL-11 influences stem cell function and the body's regenerative capacity. When this signal is blocked, cells repair themselves more effectively, inflammation decreases, and organs maintain function longer. The effect was observed in both young and older animals.
Key Research Findings
- Significant extension of lifespan across test groups
- Reduced onset and progression of age-related diseases
- Enhanced physical performance in aging organisms
- Preservation of cognitive and metabolic functions
Though conducted in animal models, these results are promising for human applications. Pharmaceutical developers are already advancing IL-11 inhibitor candidates toward clinical trials. This approach could become a cornerstone of evidence-based longevity strategies for tracking and supporting healthspan with wearables.
Source: Google News (global search)